Fulgent Genetics (FLGT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $21.34, +1.57% vs the prior close of $21.01.
- Volume 139.70K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FLGT rises 1.6% to $21.34. Closed at $21.34, +1.57% vs the prior close of $21.01. Day range $20.86–$21.50, opened at $21.05.
FLGT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — FLGT rises 1.6% to $21.34
- Closed at $21.34, +1.57% vs the prior close of $21.01. Day range $20.86–$21.50, opened at $21.05.
- Volume was 139.70K shares, 0.5x its 50-day average of 287.56K — lighter than usual.
- Price is +4.4% vs its 50-day average ($20.44) and +8.1% vs its 200-day average ($19.74).
- 52-week range $13.46–$31.04; today's close sits at 45% of that range, 31.3% below the 52-week high.
Oct 14, 2026 — FLGT ends flat (-0.2%) to $21.01, 3 down days in a row
- Closed at $21.01, -0.24% vs the prior close of $21.06. Day range $20.65–$21.44, opened at $20.84.
- Volume was 352.10K shares, 1.2x its 50-day average of 291.53K.
- Price is +3.1% vs its 50-day average ($20.38) and +6.3% vs its 200-day average ($19.76).
- 52-week range $13.46–$31.04; today's close sits at 43% of that range, 32.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — FLGT dips 1.9% to $21.06
- Closed at $21.06, -1.91% vs the prior close of $21.47. Day range $21.06–$21.60, opened at $21.47.
- Volume was 201.30K shares, 0.7x its 50-day average of 297.60K.
- Price is +3.6% vs its 50-day average ($20.33) and +6.4% vs its 200-day average ($19.79).
- 52-week range $13.46–$31.04; today's close sits at 43% of that range, 32.2% below the 52-week high.
Oct 12, 2026 — FLGT dips 1.2% to $21.47
- Closed at $21.47, -1.24% vs the prior close of $21.74. Day range $21.22–$21.80, opened at $21.74.
- Volume was 228.00K shares, 0.7x its 50-day average of 319.43K.
- Price is +6.0% vs its 50-day average ($20.26) and +8.3% vs its 200-day average ($19.82).
- 52-week range $13.46–$31.04; today's close sits at 46% of that range, 30.8% below the 52-week high.
Oct 9, 2026 — FLGT jumps 4.4% to $21.74
- Closed at $21.74, +4.42% vs the prior close of $20.82. Day range $20.82–$21.79, opened at $20.82.
- Volume was 253.90K shares, 0.8x its 50-day average of 319.91K.
- Price is +7.8% vs its 50-day average ($20.16) and +9.5% vs its 200-day average ($19.85).
- 52-week range $13.46–$31.04; today's close sits at 47% of that range, 30.0% below the 52-week high.
Oct 8, 2026 — FLGT rises 1.2% to $20.82
- Closed at $20.82, +1.22% vs the prior close of $20.57. Day range $19.82–$20.88, opened at $20.49.
- Volume was 427.90K shares, 1.4x its 50-day average of 315.69K.
- Price is +3.4% vs its 50-day average ($20.13) and +4.7% vs its 200-day average ($19.88).
- 52-week range $13.46–$31.04; today's close sits at 42% of that range, 32.9% below the 52-week high.
Oct 7, 2026 — FLGT ends flat (-0.0%) to $20.57
- Closed at $20.57, -0.05% vs the prior close of $20.58. Day range $19.90–$20.70, opened at $20.48.
- Volume was 298.30K shares, 0.9x its 50-day average of 314.93K.
- Price is +2.3% vs its 50-day average ($20.11) and +3.3% vs its 200-day average ($19.91).
- 52-week range $13.46–$31.04; today's close sits at 40% of that range, 33.7% below the 52-week high.
Oct 6, 2026 — FLGT slides 8.3% to $20.58
- Closed at $20.58, -8.33% vs the prior close of $22.45. Day range $20.46–$22.78, opened at $22.43.
- Volume was 368.60K shares, 1.2x its 50-day average of 311.98K.
- Price is +2.4% vs its 50-day average ($20.09) and +3.2% vs its 200-day average ($19.95).
- 52-week range $13.46–$31.04; today's close sits at 41% of that range, 33.7% below the 52-week high.
Oct 5, 2026 — FLGT jumps 4.5% to $22.45, a 6-month high
- Closed at $22.45, +4.52% vs the prior close of $21.48. Day range $21.28–$22.47, opened at $21.37.
- Volume was 308.00K shares, 1.0x its 50-day average of 308.74K.
- Price is +11.9% vs its 50-day average ($20.07) and +12.3% vs its 200-day average ($19.98).
- 52-week range $13.46–$31.04; today's close sits at 51% of that range, 27.7% below the 52-week high.
Oct 2, 2026 — FLGT rises 0.8% to $21.48
- Closed at $21.48, +0.85% vs the prior close of $21.30. Day range $21.07–$21.64, opened at $21.64.
- Volume was 297.60K shares, 1.0x its 50-day average of 308.83K.
- Price is +7.3% vs its 50-day average ($20.02) and +7.4% vs its 200-day average ($20.01).
- 52-week range $13.46–$31.04; today's close sits at 46% of that range, 30.8% below the 52-week high.
FLGT latest news & SEC filings
Every SEC filing by or about FLGT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gao Hanlin sold 1,673 shares at $19.66 (≈$32.89K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Xie Jian sold 2,127 shares at $19.66 (≈$41.82K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $85.39M (prior year $81.80M) (+4.4% vs Jun 30, 2025)
- Net income: -$29.53M (prior year -$18.96M) (loss widened vs Jun 30, 2025)
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade FLGT
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: May 1, 2026, Feb 27, 2026, Nov 7, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.89% (largest 8.3%).
- Liquidity: about 302.38K shares (≈$6.45M) trade per day on average.
- 52-week position: $21.34 vs a range of $13.46–$31.04 (45% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 15 sales; latest: Jian Xie sold 2,127 shares on Sep 2, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 30, 2026; 8-K Jun 2, 2026.
- Share count: 27.52M shares outstanding (Jul 27, 2026), -10.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
FLGT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 21.05 | 21.50 | 20.86 | 21.34 | 139.70K |
| Oct 14, 2026 | 20.84 | 21.44 | 20.65 | 21.01 | 352.10K |
| Oct 13, 2026 | 21.47 | 21.60 | 21.06 | 21.06 | 201.30K |
| Oct 12, 2026 | 21.74 | 21.80 | 21.22 | 21.47 | 228.00K |
| Oct 9, 2026 | 20.82 | 21.79 | 20.82 | 21.74 | 253.90K |
| Oct 8, 2026 | 20.49 | 20.88 | 19.82 | 20.82 | 427.90K |
| Oct 7, 2026 | 20.48 | 20.70 | 19.90 | 20.57 | 298.30K |
| Oct 6, 2026 | 22.43 | 22.78 | 20.46 | 20.58 | 368.60K |
| Oct 5, 2026 | 21.37 | 22.47 | 21.28 | 22.45 | 308.00K |
| Oct 2, 2026 | 21.64 | 21.64 | 21.07 | 21.48 | 297.60K |
| Oct 1, 2026 | 21.99 | 22.05 | 21.12 | 21.30 | 338.20K |
| Sep 30, 2026 | 22.07 | 22.25 | 21.69 | 22.02 | 273.50K |
| Sep 29, 2026 | 22.29 | 22.59 | 21.88 | 22.08 | 234.80K |
| Sep 28, 2026 | 21.99 | 22.39 | 21.83 | 22.36 | 248.60K |
| Sep 25, 2026 | 21.69 | 22.25 | 21.36 | 22.20 | 247.00K |
| Sep 24, 2026 | 21.28 | 21.87 | 21.27 | 21.55 | 369.60K |
| Sep 23, 2026 | 21.52 | 21.63 | 21.12 | 21.27 | 190.30K |
| Sep 22, 2026 | 21.52 | 21.84 | 21.35 | 21.65 | 252.30K |
| Sep 21, 2026 | 21.93 | 21.93 | 21.01 | 21.54 | 348.80K |
| Sep 18, 2026 | 21.70 | 21.88 | 21.41 | 21.69 | 669.20K |
About Fulgent Genetics
Fulgent Genetics (FLGT) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in EL MONTE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1674930.
FLGT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Linda Dong | Director | May 18, 2026 |
| Regina E Groves | Director | May 18, 2026 |
| Ming Hsieh | Chief Executive Officer | Sep 3, 2026 |
| Michael Nohaile | Director | May 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hanlin Gao | Chief Scientific Officer | Sep 3, 2026 |
| Ming Hsieh | Chief Executive Officer | Sep 3, 2026 |
| Paul Kim | CFO and Treasurer | Sep 3, 2026 |
| Jian Xie | President and COO | Sep 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Jian Xie | Sale | 2,127 | $19.66 |
| Sep 2, 2026 | Hanlin Gao | Sale | 1,673 | $19.66 |
| Aug 27, 2026 | Hanlin Gao | Sale | 939 | $19.91 |
| Aug 27, 2026 | Jian Xie | Sale | 1,193 | $19.91 |
| Jun 2, 2026 | Jian Xie | Sale | 2,146 | $17.89 |
| Jun 2, 2026 | Hanlin Gao | Sale | 1,688 | $17.89 |
| May 27, 2026 | Jian Xie | Sale | 1,201 | $17.60 |
| May 27, 2026 | Hanlin Gao | Sale | 945 | $17.60 |
| Dec 2, 2025 | Jian Xie | Sale | 1,140 | $28.33 |
| Dec 2, 2025 | Hanlin Gao | Sale | 1,075 | $28.33 |
| Nov 28, 2025 | Jian Xie | Sale | 1,198 | $29.57 |
| Nov 28, 2025 | Hanlin Gao | Sale | 943 | $29.57 |
| Nov 24, 2025 | Hanlin Gao | Sale | 535 | $30.47 |
| Nov 24, 2025 | Jian Xie | Sale | 681 | $30.47 |
| Nov 19, 2025 | Jian Xie | Sale | 10,000 | $29.10 |
FLGT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $322.67M | $-60.51M | — | $-101.64M |
| Dec 31, 2024 | $283.47M | $-42.71M | — | $21.06M |
| Dec 31, 2023 | $289.21M | $-167.82M | — | $27.00M |
| Dec 31, 2022 | $618.97M | $143.40M | — | $253.52M |
| Dec 31, 2021 | $992.58M | $507.36M | — | $538.58M |
Latest balance sheet: total assets $1.09B, total liabilities $93.24M, cash $26.30M (as of Jun 30, 2026).
FLGT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $20.21 |
| May 1, 2026 | 8-K Item 2.02 (results) | $14.13 |
| Feb 27, 2026 | 8-K Item 2.02 (results) | $15.33 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $26.36 |
| Aug 1, 2025 | 8-K Item 2.02 (results) | $18.53 |
| May 2, 2025 | 8-K Item 2.02 (results) | $20.54 |
| Feb 28, 2025 | 8-K Item 2.02 (results) | $15.45 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $19.43 |
| Aug 2, 2024 | 8-K Item 2.02 (results) | — |
| May 3, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 3, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Celcuity (CELC)Caris Life Sciences (CAI)Grail (GRAL)CareDx (CDNA)Fortrea (FTRE)Veracyte (VCYT)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on FLGT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.